INT312738

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.45
First Reported 2010
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 4
Disease Relevance 1.04
Pain Relevance 0.94

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

endoplasmic reticulum (UGT2B17)
UGT2B17 (Homo sapiens)
Pain Link Frequency Relevance Heat
cINOD 16 99.48 Very High Very High Very High
diclofenac 4 92.80 High High
Pain 4 92.40 High High
Bioavailability 4 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Obesity 44 95.20 Very High Very High Very High
Renal Disease 72 93.24 High High
Pain 4 92.40 High High
INFLAMMATION 4 91.56 High High
Proteinuria 8 86.76 High High
Keloid Scars 8 84.52 Quite High
Injury 32 83.96 Quite High
Renal Failure 8 68.96 Quite High
Focal Segmental Glomerulosclerosis 20 46.32 Quite Low
Urinary Tract Infection 4 18.72 Low Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Following the paper by Schulze and colleagues [18] on the effect of UGT2B17 gene deletion polymorphism on doping tests, it is likely that this discovery is turned into practice and abused by athletes determined to use AAS.
Regulation (effect) of UGT2B17
1) Confidence 0.45 Published 2010 Journal Subst Abuse Treat Prev Policy Section Body Doc Link PMC2877023 Disease Relevance 0.07 Pain Relevance 0
As the hypothesis is based on the dysergistic effect of the UGT2B17 polymorphism and long term exposure to AAS, a single clinical trial approach does not present a feasible way to generate evidence to support or refute the hypothesis.
Regulation (effect) of UGT2B17
2) Confidence 0.45 Published 2010 Journal Subst Abuse Treat Prev Policy Section Body Doc Link PMC2877023 Disease Relevance 0.58 Pain Relevance 0
The inhibitory effect was also found to be dependent on the UGT2B17 genotype.
Regulation (dependent) of UGT2B17
3) Confidence 0.45 Published 2010 Journal Subst Abuse Treat Prev Policy Section Body Doc Link PMC2877023 Disease Relevance 0.23 Pain Relevance 0.46
Compared to UGT2B17, UGT2B15 was found to be more sensitive to both the NSAIDs, particularly ibuprofen.
Regulation (sensitive) of UGT2B17 associated with cinod
4) Confidence 0.12 Published 2010 Journal Subst Abuse Treat Prev Policy Section Body Doc Link PMC2877023 Disease Relevance 0.15 Pain Relevance 0.47

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox